--- title: "Assessing ExlService Hldgs: Insights From 4 Financial Analysts" type: "News" locale: "en" url: "https://longbridge.com/en/news/277090721.md" description: "During the last three months, four analysts evaluated ExlService Hldgs (NASDAQ:EXLS), showing a range of sentiments from bullish to bearish. The average 12-month price target is $45.5, down from $53.00, with a high estimate of $51.00 and a low of $40.00. Analysts have lowered their ratings, reflecting changing market conditions. ExlService Hldgs has shown strong financial performance with a revenue growth rate of 12.18%, a net margin of 10.98%, and a return on equity of 5.78%. The company maintains a balanced debt approach with a debt-to-equity ratio of 0.46." datetime: "2026-02-26T20:00:57.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277090721.md) - [en](https://longbridge.com/en/news/277090721.md) - [zh-HK](https://longbridge.com/zh-HK/news/277090721.md) --- # Assessing ExlService Hldgs: Insights From 4 Financial Analysts During the last three months, 4 analysts shared their evaluations of ExlService Hldgs (NASDAQ:EXLS), revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. **Bullish** **Somewhat Bullish** **Indifferent** **Somewhat Bearish** **Bearish** **Total Ratings** 4 0 0 0 0 **Last 30D** 3 0 0 0 0 **1M Ago** 0 0 0 0 0 **2M Ago** 1 0 0 0 0 **3M Ago** 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $45.5, along with a high estimate of $51.00 and a low estimate of $40.00. A 14.15% drop is evident in the current average compared to the previous average price target of $53.00. ![price target chart](https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1772136054_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg) ## Analyzing Analyst Ratings: A Detailed Breakdown A clear picture of ExlService Hldgs's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jared Levine TD Cowen Lowers Buy $45.00 $51.00 David Grossman Stifel Lowers Buy $46.00 $54.00 Mayank Tandon Needham Lowers Buy $40.00 $55.00 Bryan Bergin TD Cowen Lowers Buy $51.00 $52.00 ### Key Insights: - **Action Taken:** Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ExlService Hldgs. This information provides a snapshot of how analysts perceive the current state of the company. - **Rating:** Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of ExlService Hldgs compared to the broader market. - **Price Targets:** Understanding forecasts, analysts offer estimates for ExlService Hldgs's future value. Examining the current and prior targets provides insight into analysts' changing expectations. Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of ExlService Hldgs's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table. Stay up to date on ExlService Hldgs analyst ratings. ## Discovering ExlService Hldgs: A Closer Look ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America. ### ExlService Hldgs's Financial Performance **Market Capitalization Analysis:** Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity. **Revenue Growth:** ExlService Hldgs's remarkable performance in 3M is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of **12.18%**. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers. **Net Margin:** ExlService Hldgs's net margin excels beyond industry benchmarks, reaching **10.98%**. This signifies efficient cost management and strong financial health. **Return on Equity (ROE):** ExlService Hldgs's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive **5.78%** ROE, the company effectively utilizes shareholder equity capital. **Return on Assets (ROA):** ExlService Hldgs's ROA stands out, surpassing industry averages. With an impressive ROA of **3.38%**, the company demonstrates effective utilization of assets and strong financial performance. **Debt Management:** The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at **0.46**. ## The Significance of Analyst Ratings Explained Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter. Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors. This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [EXLS.US](https://longbridge.com/en/quote/EXLS.US.md) ## Related News & Research - [Oruka Therapeutics (ORKA) Receives a Rating Update from a Top Analyst](https://longbridge.com/en/news/282540371.md) - [Amylyx Pharmaceuticals (AMLX) Is Up 15.9% After FDA ALS Drug Approval Boosts Analyst Optimism – Has The Bull Case Changed?](https://longbridge.com/en/news/282375662.md) - [Capricor Therapeutics (CAPR) Gets a Buy from Roth MKM](https://longbridge.com/en/news/282746660.md) - [RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)](https://longbridge.com/en/news/282768248.md) - [IBM stock is having its worst year since 2002. Why this analyst says buy.](https://longbridge.com/en/news/282470427.md)